Shift‐workers show an increased incidence of type 2 diabetes mellitus (T2DM). A possible mechanism is the disruption of the circadian timing of glucose homeostasis. Skeletal muscle mitochondrial function is modulated by the molecular clock. We used time‐restricted feeding (TRF) during the inactive phase to investigate how mistimed feeding affects muscle mitochondrial metabolism. Rats on an ad libitum (AL) diet were compared to those that could eat only during the light (inactive) or dark (active) phase. Mitochondrial respiration, metabolic gene expressions, and metabolite concentrations were determined in the soleus muscle. Rats on AL feeding or dark‐fed TRF showed a clear daily rhythm in muscle mitochondrial respiration. This rhythm in mitochondrial oxidative phosphorylation capacity was abolished in light‐fed TRF animals and overall 24h respiration was lower. The expression of several genes involved in mitochondrial biogenesis and the fission/fusion machinery was altered in light‐fed animals. Metabolomics analysis indicated that light‐fed animals had lost rhythmic levels of α‐ketoglutarate and citric acid. Contrastingly, lipidomics showed that light‐fed animals abundantly gained rhythmicity in levels of triglycerides. Furthermore, while the RER shifted entirely with the food intake in the light‐fed animals, many measured metabolic parameters (e.g., activity and mitochondrial respiration) did not strictly align with the shifted timing of food intake, resulting in a mismatch between expected metabolic supply/demand (as dictated by the circadian timing system and light/dark‐cycle) and the actual metabolic supply/demand (as dictated by the timing of food intake). These data suggest that shift‐work impairs mitochondrial metabolism and causes metabolic inflexibility, which can predispose to T2DM.

Restricted feeding is well known to affect expression profiles of both clock and metabolic genes. However, it is unknown whether these changes in metabolic gene expression result from changes in the molecular clock or in feeding behavior. Here we eliminated the daily rhythm in feeding behavior by providing 6 meals evenly distributed over the light/dark-cycle. Animals on this 6-meals-a-day feeding schedule retained the normal day/night difference in physiological parameters including body temperature and locomotor activity. The daily rhythm in respiratory exchange ratio (RER), however, was significantly phase-shifted through increased utilization of carbohydrates during the light phase and increased lipid oxidation during the dark phase. This 6-meals-a-day feeding schedule did not have a major impact on the clock gene expression rhythms in the master clock, but did have mild effects on peripheral clocks. In contrast, genes involved in glucose and lipid metabolism showed differential expression. In conclusion, eliminating the daily rhythm in feeding behavior in rats does not affect the master clock and only mildly affects peripheral clocks, but disturbs metabolic rhythms in liver, skeletal muscle and brown adipose tissue in a tissue-dependent manner. Thereby, a clear daily rhythm in feeding behavior strongly regulates timing of peripheral metabolism, separately from circadian clocks.

Objective: Epidemiological studies show that shift workers are at increased risk for type 2 diabetes. As modern societies increasingly require shift work, it seems crucial to determine whether there are long‐lasting health effects of rotational shifts.Methods: This study examined the after‐effects of 4 weeks of time‐restricted feeding (TRF) during the light period (= light‐fed) in rats, an animal model for shift work. This study also included a TRF‐dark (= dark‐fed) control group. The aligned and misaligned feeding times of light and dark feeding are associated with poor and good health outcomes, respectively. Several physiological measures were monitored continuously; blood, liver, brown adipose tissue, and soleus and gastrocnemius muscle were collected following 11 days of ad libitum (AL) feeding after ending the TRF.Results: In the dark‐fed animals, the day/night differences in food intake, activity, and respiratory exchange ratio were still enhanced at the end of the experiment. Light‐fed animals displayed the smallest day/night differences for these measures, as well as for body temperature. In both the light‐ and dark‐fed animals, rhythms in plasma glucose, nonesterified fatty acids, and gene expression had not fully recovered after 11 days of AL feeding. Importantly, the effects on gene expression were both tissue and gene dependent.Conclusions: Our data indicate that rotational shift workers may have an increased risk of long‐lasting disturbed rhythms in several physiological measures after a period of shift work. Clearly, such disturbances may harm their health.

Restricted feeding is well known to affect expression profiles of both clock and metabolic genes. However, it is unknown whether these changes in metabolic gene expression result from changes in the molecular clock or in feeding behavior. Here we eliminated the daily rhythm in feeding behavior by providing 6-meals evenly distributed over the light/dark-cycle. Animals on this 6-meals-a-day feeding schedule retained the normal day/night difference in physiological parameters including body temperature and locomotor activity. The daily rhythm in respiratory exchange ratio (RER), however, was significantly phase-shifted through increased utilization of carbohydrates during the light phase and increased lipid oxidation during the dark phase. This 6-meals-a-day feeding schedule did not have a major impact on the clock gene expression rhythms in the master clock but did have mild effects on peripheral clocks. By contrast, genes involved in glucose and lipid metabolism showed differential expression. Concluding, eliminating the daily rhythm in feeding behavior in rats does not affect the master clock and only mildly affects peripheral clocks, but disturbs metabolic rhythms in liver, skeletal muscle and brown adipose tissue in a tissue-dependent manner. Thereby a clear daily rhythm in feeding behavior strongly regulates timing of peripheral metabolism, separately from circadian clocks.

Background: ExPEC9V was a 9-valent vaccine candidate intended for the prevention of invasive extraintestinal pathogenic Escherichia coli (ExPEC) disease (IED). Here, we describe more than a decade-long formulation development trajectory of this vaccine candidate aimed at establishing a stable, robust and scalable drug product that maintains long-term stability while addressing potential manufacturing challenges and increasing the probability of successful global deployment. Methods: Selected formulation development studies of the ExPEC multivalent vaccine candidate are summarized, spanning formulation screening, confirmation, and design of experiments (DoE)-based robustness, stability and compatibility studies. A formulation initially developed for an early low-valency vaccine candidate was subsequently tested and confirmed for candidates with additional serotypes incorporated based on antigen heterogeneity evidence. Contact materials employed included primary packaging—polycarbonate (PC) and polyethylene terephthalate glycol (PETG) bottles, borosilicate glass vials, stoppers, and prefilled syringes; vessel types—bags and stainless steel vessels used in drug substance (DS) and drug product (DP) manufacturing; and varying concentrations of tungsten and hydrogen peroxide. An evolving analytical panel was applied to assess attributes such as purity, protein concentration and degree of O-acetylation. Results: A phosphate-based formulation containing sorbitol, methionine, and polysorbate 80 showed superior stability in screening and was confirmed as fit for purpose across increasing vaccine valency. The ExPEC 9V drug product displayed remarkable thermal and formulation robustness, long-term (3 years) stability at 2–8 °C in glass vials and prefilled syringes, and compatibility with assessed primary containers and manufacturing materials. DoE-based robustness studies defined acceptable excipient and pH ranges, supporting a wide formulation design space. Conclusions: The development trajectory of the ExPEC9V vaccine candidate demonstrates that early prioritization of a robust, scalable formulation that remains fit for purpose across valency evolution supports a stable late-stage manufacturable drug product.